![Gregory Ciongoli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Ciongoli
Président chez
ATARA BIOTHERAPEUTICS, INC.
Fortune : 13 M $ au 30/06/2026
Profil
Gregory A. Ciongoli is the founder of Adiumentum Capital Management LLC.
Mr. Ciongoli is currently Chairman at Atara Biotherapeutics, Inc. starting in 2025 and Director at Zymeworks, Inc. starting in 2025.
Mr. Ciongoli was a Partner at The Baupost Group LLC.
Mr. Ciongoli earned an MBA from Harvard Business School and completed undergraduate studies at the Woodrow Wilson School of Public & International Affairs.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZYMEWORKS INC. 0,68 % | 12/01/2026 | 493 500 ( 0,68 % ) | 13 M $ | 30/06/2026 |
| 09/06/2026 | 12 000 ( 0,13 % ) | 137 760 $ | 30/06/2026 |
Postes actifs de Gregory Ciongoli
| Sociétés | Poste | Début |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Président | 03/09/2025 |
| ZYMEWORKS INC. | Directeur/Membre du Conseil | 11/08/2025 |
Anciens postes connus de Gregory Ciongoli
| Sociétés | Poste | Fin |
|---|---|---|
The Baupost Group LLC
 The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Corporate Officer/Principal | - |
Formation de Gregory Ciongoli
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Baupost Group LLC
The Baupost Group LLC Investment ManagersFinance Baupost is an opportunistic, value-oriented, open mandate investor that seeks to invest their capital to achieve attractive risk-adjusted returns over an extended period of time. The firm seeks to invest in assets which are undervalued relative to their market price. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Woodrow Wilson School of Public & International Affairs
 Woodrow Wilson School of Public & International Affairs Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
